28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Related
A federal district court in Washington recently held that a claims handling mishap resulted in a wai...
Read More >
Presently, an employee alleging harassment, discrimination, or other claim under California’s Fair ...
Read More >
A tough situation. Could it have been handled better? The Pennsylvania Department of Insurance will...
Read More >
With immigration enforcement in the news, some employers may be wondering what responsibilities they...
Read More >
In this podcast I am joined by AMI Managing Director Don Stern. We consider how defense counsel can ...
Read More >
Rutledge v. Pharmaceutical Care Management Ass’n, No. 18-540. Most states have enacted legislation...
Read More >